Evidence map›Paper›PMID 37893845›Full record

ArticleHealthcare (Basel, Switzerland)2023

Evaluation of the Effect of a Safe Medication Strategy on Potentially Inappropriate Medications, Polypharmacy and Anticholinergic Burden for People with Dementia: An Intervention Study.

Ashley Kable, Samantha Fraser, Anne Fullerton, Carolyn Hullick, Kerrin Palazzi, Christopher Oldmeadow, Constance Dimity Pond, Andrew Searles, Rod Ling, Remia Bruce and 2 more

Abstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ashley KableSchool of Nursing and Midwifery, College of Health, Medicine and Wellbeing, University of Newcastle, University Drive, Callaghan, NSW 2308, Australia.ORCID 0000-0002-1205-7712
Samantha FraserHunter New England Local Health District, Rankin Park, Newcastle, NSW 2287, Australia.
Anne FullertonHunter New England Local Health District, Rankin Park, Newcastle, NSW 2287, Australia.
Carolyn HullickHunter New England Local Health District, Rankin Park, Newcastle, NSW 2287, Australia.
Kerrin PalazziHunter Medical Research Institute, New Lambton Heights, Newcastle, NSW 2305, Australia.
Christopher OldmeadowHunter Medical Research Institute, New Lambton Heights, Newcastle, NSW 2305, Australia.
Constance Dimity PondSchool of Medicine and Public Health, College of Health, Medicine and Wellbeing, University of Newcastle, University Drive, Callaghan, NSW 2308, Australia.
Andrew SearlesHunter Medical Research Institute, New Lambton Heights, Newcastle, NSW 2305, Australia.
Rod LingHunter Medical Research Institute, New Lambton Heights, Newcastle, NSW 2305, Australia.
Remia BruceHunter New England Local Health District, Rankin Park, Newcastle, NSW 2287, Australia.
Wendy MurdochHunter New England Local Health District, Rankin Park, Newcastle, NSW 2287, Australia.
John AttiaHunter New England Local Health District, Rankin Park, Newcastle, NSW 2287, Australia.

Funding

Australian Government under the Dementia and Aged Care Services Fund: Research and Innovation Grants Scheme 1601301
6 · The paper itself

Abstract

People with dementia (PWD) are at risk for medication-related harm due to their impaired cognition and frequently being prescribed many medications. This study evaluated a medication safety intervention (including pharmacist medication reconciliation and review) for PWD during an unplanned admission to hospital. This article reports the effect of the intervention on polypharmacy, potentially inappropriate medications (PIMs), and anticholinergic burden scores for PWD. A pre-post design using an intervention site and a control site was conducted in 2017-2019, in a regional area in New South Wales, Australia. Polypharmacy, PIMs, and anticholinergic burden were measured at admission, discharge, and three months after discharge. There were 628 participants including 289 at the control site and 339 at the intervention site. Polypharmacy was 95% at admission and 90% at discharge. PIMs at admission were 95-98% across timepoints and decreased significantly at discharge. The mean anticholinergic score decreased significantly between admission (2.40-3.15) and discharge (2.01-2.57). Reduced PIMs at discharge were correlated with reduced anticholinergic burden (rho = 0.48-0.55,

Indexed as

acute careanticholinergic burdendementiamedication reconciliationmedicationspolypharmacy

Identifiers

PMID37893845
PMCPMC10606387

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.